학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 124건 | 목록
1~20
Academic Journal
Ruffle, James K. ; Gray, Robert J ; Mohinta, Samia ; Pombo, Guilherme ; Kaul, Chaitanya ; Hyare, Harpreet ; Rees, Geraint ; Nachev, Parashkev
In NeuroImage 1 May 2024 291
Academic Journal
Akhave N; The University of Texas MD Anderson Cancer Center, Houston, TX.; Song Z; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; Hong DS; The University of Texas MD Anderson Cancer Center, Houston, TX.; Gray RJ; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; Wang V; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.; Hamilton SR; City of Hope National Medical Center, Duarte, CA.; Takebe N; Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Tricoli JV; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Conley BA; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX.; Harris LN; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA.; Chen AP; Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Coleman N; Trinity College Dublin Dublin Ireland.; Wei Z; Dana-Farber Cancer Institute Boston, MA United States.; Iafrate AJ; Massachusetts General Hospital Boston, MA United States.; Zwiebel JA; National Cancer Institute Bethesda, MD United States.; Sharon E; Dana-Farber Cancer Institute Boston, MA United States.; Gray RJ; Dana-Farber Cancer Institute Boston, MA United States.; Wang V; Dana-Farber Cancer Institute United States.; McShane LM; National Institutes of Health Bethesda, MD United States.; Rubinstein LV; National Institutes of Health, National Cancer Institute Bethesda, MD United States.; Patton DR; National Cancer Institute Bethesda, MD United States.; Williams PM; Frederick National Laboratory for Cancer Research United States.; Hamilton SR; City Of Hope National Medical Center Irwindale, California United States.; Takebe N; OU Health Stephenson Cancer Center Oklahoma City, Oklahoma United States.; Williams T; St. Luke's Mountain States Tumor Institute Boise, ID United States.; Croley JJ; Saint Joseph Hospital East United States.; Onitilo AA; Wisconsin NCORP Weston, Wisconsin United States.; Tricoli JV; National Cancer Institute Rockville, MD United States.; Cheng J; Broad Institute United States.; Karlovich C; Frederick National Laboratory for Cancer Research Frederick, MD United States.; Conley BA; National Cancer Institute Northport, MI United States.; Arteaga CL; The University of Texas Southwestern Medical Center Dallas, Texas United States.; Harris L; National Cancer Institute Rockville, MD United States.; O'Dwyer PJ; University of Pennsylvania Philadelphia, PA United States.; Hong DS; The University of Texas MD Anderson Cancer Center Houston, Texas United States.; Chen AP; National Cancer Institute Bethesda, MD United States.; Flaherty KT; Massachusetts General Hospital Cancer Center Boston, MA United States.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Salama AKS; Duke University, Durham, NC.; Wang V; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistical Center, Boston, MA.; Macrae ER; Columbus Oncology and Hematology Associates, Columbus, OH.; Park JI; Medical College of Wisconsin, Milwaukee, WI.; Chen HX; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Gray RJ; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistical Center, Boston, MA.; McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Patton D; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, MD.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.; Hamilton SR; City of Hope National Medical Center and Comprehensive Cancer Center, Duarte, CA.; Armstrong DK; Johns Hopkins University, Baltimore, MD.; Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Conley BA; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Arteaga CL; University of Texas Southwestern Medical Center, Dallas, TX.; Harris LN; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA.; Chen AP; Division of Cancer Treatment and Diagnosis, Developmental Therapeutics Clinic, NCI, Bethesda, MD.; Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Tsao AS; The University of Texas MD Anderson Cancer Center, Houston, TX.; Song Z; Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; Ho AL; Memorial Sloan Kettering Cancer Center, New York, NY.; Mehnert JM; Laura and Issac Perlmutter Cancer Center, New York, NY.; Ivy P; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Gray RJ; Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; Wang V; Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; McShane LM; Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Rockville, MD.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.; Hamilton SR; City of Hope National Medical Center, Duarte, CA.; Takebe N; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Ajumally R; University of Oklahoma Health Science Center, Oklahoma City, OK.; Silhavy J; Illumina, Inc, San Diego, CA.; Rahmanian S; Illumina, Inc, San Diego, CA.; Das B; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD.; Chen L; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD.; Karlovich C; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD.; Lococo JS; Illumina, Inc, San Diego, CA.; Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Conley BA; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Arteaga CL; University of TX Southwestern Medical Center, Dallas, TX.; Harris LN; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; O'Dwyer PJ; University of Pennsylvania, Pennsylvania Hospital, Philadelphia, PA.; Chen AP; Division of Cancer Treatment and Diagnosis, Developmental Therapeutics Clinic, National Cancer Institute, Bethesda, MD.; Flaherty KT; Massachusetts General Hospital, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Janku F; Division of Cancer Medicine, Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX.; Jegede OA; ECOG-ACRIN Biostatistics Center, Dana-Farber Cancer Institute, Boston, MA.; Puhalla SL; University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.; Konstantinopoulos PA; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Meric-Bernstam F; Division of Cancer Medicine, Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX.; Zwiebel JA; Division of Cancer Treatment and Diagnosis, Investigational Drug Branch, National Cancer Institute, Bethesda, MD.; Gray RJ; ECOG-ACRIN Biostatistics Center, Dana-Farber Cancer Institute, Boston, MA.; Wang XV; ECOG-ACRIN Biostatistics Center, Dana-Farber Cancer Institute, Boston, MA.; McShane LM; Division of Cancer Treatment and Diagnosis, Biometric Research Program, National Cancer Institute, Bethesda, MD.; Rubinstein LV; Division of Cancer Treatment and Diagnosis, Biometric Research Program, National Cancer Institute, Bethesda, MD.; Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.; Hamilton SR; City of Hope National Medical Center, Duarte, CA.; Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Ghani S; University of Oklahoma Health Science Center, Oklahoma City, OK.; Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX.; Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA.; Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Damodaran, Senthil; Zhao, Fengmin; Deming, Dustin A; Mitchell, Edith P; Wright, John J; Gray, Robert J; Wang, Victoria; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Suga, Jennifer M; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T
Academic Journal
Albain, Kathy S; Gray, Robert J; Makower, Della F; Faghih, Amir; Hayes, Daniel F; Geyer, Charles E; Dees, Elizabeth C; Goetz, Matthew P; Olson, John A; Lively, Tracy; Badve, Sunil S; Saphner, Thomas J; Wagner, Lynne I; Whelan, Timothy J; Ellis, Matthew J; Wood, William C; Keane, Maccon M; Gomez, Henry L; Reddy, Pavan S; Goggins, Timothy F
Academic Journal
Academic Journal
Ligon RA; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA; Children's Healthcare of Atlanta Cardiology, Atlanta, Georgia, USA. Electronic address: ligona@kidsheart.com.; Nageotte SJ; Department of Pediatrics, Loma Linda University Children's Hospital, Loma Linda, California, USA.; Kheiwa A; Department of Cardiology, Adult Congenital Heart Disease Program, Loma Linda University Medical Center, Loma Linda, California, USA.; Gray RJ; Department of Pediatric Cardiology University of Utah and Primary Children's Hospital, Salt Lake City, Utah, USA.; Ghez O; Department of Cardiovascular Diseases, Sidra Medicine, Doha, Qatar.; Hijazi ZM; Department of Cardiovascular Diseases, Sidra Medicine, Doha, Qatar.; McElhinney DB; Departments of Cardiothoracic Surgery and Pediatrics, Stanford University School of Medicine, Palo Alto, California, USA.; Babaliaros VC; Division of Cardiology, Emory Structural Heart and Valve Center, Emory University Hospital Midtown, Atlanta, Georgia, USA.; Kim DW; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA; Children's Healthcare of Atlanta Cardiology, Atlanta, Georgia, USA.; Boucek DM; Department of Pediatric Cardiology University of Utah and Primary Children's Hospital, Salt Lake City, Utah, USA.; Gordon BM; Department of Pediatrics, Rady Children's Hospital/University of California-San Diego School of Medicine, San Diego, California, USA.
Publisher: Elsevier Inc Country of Publication: Netherlands NLM ID: 101757292 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-0849 (Electronic) Linking ISSN: 26660849 NLM ISO Abbreviation: JACC Case Rep Subsets: PubMed not MEDLINE
Academic Journal
Gouda MA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.; Wei Z; Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA.; Rodon J; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.; Davies MA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.; Janku F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.; Gray RJ; Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA.; Wang V; Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA.; McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.; Hamilton SR; City of Hope National Medical Center and Comprehensive Cancer Center, Duarte, CA.; Liu R; Department of Hematology Oncology, The Permanente Medical Group, San Francisco, CA.; Bota DA; UCI Health Chao Family Comprehensive Cancer Center, Orange, CA.; Swiecicki PL; University of Michigan Rogel Cancer Center, Ann Arbor, MI.; Buchschacher GL; Kaiser Permanente Southern California, Los Angeles, CA.; Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Conley BA; UT Southwestern Simmons Cancer Center, Dallas, TX.; Arteaga CL; UT Southwestern Simmons Cancer Center, Dallas, TX.; Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA.; Chen AP; Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
O'Hara MH; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania.; Jegede O; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts.; Dickson MA; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.; DeMichele AM; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania.; Piekarz R; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Gray RJ; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts.; Wang V; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts.; McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Patton DR; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Hamilton SR; City of Hope National Medical Center, Duarte, California.; Onitilo A; Marshfield Medical Center - Weston, Weston, Wisconsin.; Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Arteaga CL; UT Southwestern Simmons Cancer Center, Dallas, Texas.; Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; O'Dwyer PJ; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania.; Chen AP; Division of Cancer Treatment and Diagnosis, Developmental Therapeutics Clinic, National Cancer Institute, Bethesda, Maryland.; Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Clinical Trials; Dec2019, Vol. 16 Issue 6, p673-681, 9p, 4 Charts, 2 Graphs
Academic Journal
Zauderer MG; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY and Westchester Medical Center and New York Medical College, Valhalla, NY.; Jegede O; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; Jackman DM; Dana Farber Cancer Institute, Boston, MA.; Zwiebel JA; Investigational Drug Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Gray RJ; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; Wang V; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Patton DR; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, MD.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.; Hamilton SR; City of Hope National Medical Center, Duarte, CA.; Takebe N; Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Huang R; Brigham and Women's Hospital, Boston, MA.; Carrillo JA; University of California, Irvine, CA.; Brenner AJ; University of Texas Health Sciences Center, San Antonio, TX.; Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX.; Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA.; Chen AP; Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Gien LT; Odette Cancer Centre-Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Song Z; Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA.; Poklepovic A; Virginia Commonwealth University/Massey Cancer Center, Richmond, VA.; Collisson EA; Fred Hutchinson Cancer Center, Seattle, WA.; Zwiebel JA; Investigational Drug Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Gray RJ; Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA.; Wang V; Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA.; McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.; Deceased.; Hamilton SR; City of Hope National Medical Center, Duarte, CA.; Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX.; Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA.; Chen AP; Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Flaherty KT; Massachusetts General Hospital Cancer Center; Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Gray, Robert J
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어